Abcellera Biologics shares owned by Belmont Capital
Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Belmont Capital
from 13F filings
Historical chart of Belmont Capital investment in Abcellera Biologics
Tip: Access up to 7 years of quarterly data
All positions including Abcellera Biologics held by Belmont Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Abcellera Biologics by Belmont Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.2M | 260k | 4.53 |
| 2023-09-30 | $2.3M | 510k | 4.60 |
| 2023-06-30 | $3.3M | 510k | 6.46 |
| 2023-03-31 | $3.8M | 510k | 7.54 |
| 2022-12-31 | $5.2M | 510k | 10.13 |
| 2022-09-30 | $5.0M | 510k | 9.89 |
| 2022-06-30 | $533k | 50k | 10.66 |
| 2022-03-31 | $975k | 100k | 9.75 |
| 2021-12-31 | $2.1M | 150k | 14.30 |
| 2021-09-30 | $3.0M | 150k | 20.04 |
| 2021-06-30 | $3.3M | 150k | 22.00 |